ConductScience.org, home

Paper856236

Assessment of response to therapy in advanced breast cancer.

Hayward JL and 5 others. Br J Cancer, 1977. Cited by 387 papers, by iCite.

Cite this record

ConductScience Library. Assessment of response to therapy in advanced breast cancer. Papers, record 856236. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/856236

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Assessment of response to therapy in advanced breast cancer.
PubMed
Journal
Br J Cancer
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
387
iCite
Relative citation ratio, by iCite
11.4
iCite
Revised in PubMed
2019-05-15
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hayward JLJ L
2Carbone PPP P
3Heusen JCJ C
4Kumaoka SS
5Segaloff AA
6Rubens RDR D

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Activities of Daily Living
Female
Humans
Neoplasm Metastasis
Research Design

Cited by129

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 387 citations.

PMIDTitleJournalYearIn PapersSource
39955339Effect of neoadjuvant chemotherapy on CD14 + CD16 + monocytes and soluble CD163 in Egyptian breast cancer patients.Sci Rep2025https://conductscience.org/library/papers/39955339PubMed
3902224618F-fluorodeoxyglucose positron emission tomography-computed tomography in the localization of the lesions in the osteogenic region of breast cancer bone metastases after therapy.Quant Imaging Med Surg2024https://conductscience.org/library/papers/39022246PubMed
36961572Computed tomography density changes of bone metastases after concomitant denosumab.Skeletal Radiol2023https://conductscience.org/library/papers/36961572PubMed
36092784Breast MRI Tumor Automatic Segmentation and Triple-Negative Breast Cancer Discrimination Algorithm Based on Deep Learning.Comput Math Methods Med2022https://conductscience.org/library/papers/36092784PubMed
35751095DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival.Breast Cancer Res2022https://conductscience.org/library/papers/35751095PubMed
35419519The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab.Neurooncol Adv2022https://conductscience.org/library/papers/35419519PubMed
33226492Patterns of biomarker expression in patients treated with primary endocrine therapy - a unique insight using core needle biopsy tissue microarray.Breast Cancer Res Treat2021https://conductscience.org/library/papers/33226492PubMed
33037978Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins.J Mol Histol2020https://conductscience.org/library/papers/33037978PubMed
32154098Bone metastases in thyroid cancer.J Bone Oncol2020https://conductscience.org/library/papers/32154098PubMed
30050402Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis.Front Neurosci2018https://conductscience.org/library/papers/30050402PubMed
28522855Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer.Sci Rep2017https://conductscience.org/library/papers/28522855PubMed
27399922EZH2 Protein Expression and Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.Rev Bras Ginecol Obstet2016https://conductscience.org/library/papers/27399922PubMed
27106355Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study.Croat Med J2016https://conductscience.org/library/papers/27106355PubMed
26943585Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells' sensitivity to paclitaxel.Oncotarget2016https://conductscience.org/library/papers/26943585PubMed
26909251Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases.J Bone Oncol2012https://conductscience.org/library/papers/26909251PubMed
26657294Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer.Oncotarget2016https://conductscience.org/library/papers/26657294PubMed
26004085Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo.Mol Oncol2015https://conductscience.org/library/papers/26004085PubMed
24396494Current approaches, challenges and future directions for monitoring treatment response in prostate cancer.J Cancer2014https://conductscience.org/library/papers/24396494PubMed
24350285Usefulness of traditional serum biomarkers for management of breast cancer patients.Biomed Res Int2013https://conductscience.org/library/papers/24350285PubMed
23849542GPER-1 acts as a tumor suppressor in ovarian cancer.J Ovarian Res2013https://conductscience.org/library/papers/23849542PubMed

See all 129 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/856236

GET https://conductscience.org/api/papers/v1/856236/cited_by?page=2